Neuren Pharmaceuticals | Betriebsaufwand



Operating Expenses Veränderung Datum
Alaunos Therapeutics USD 759K 391K 2024-12
Avita Medical AUD 28.36M 2.44M 2024-12
Clinuvel Pharmaceuticals AUD 20.71M 2.35M 2024-06
Dianthus Therapeutics USD 35.12M 1.88M 2025-06
Genetic Signatures AUD 24.53M 8.13M 2024-12
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Medical Developments International AUD 19.8M 9.46M 2024-12
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organon & Co USD 1.27B 144M 2025-06
Paradigm Biopharmaceuticals AUD 6.36M 8.6M 2024-12
PYC Therapeutics AUD 38.58M 20.29M 2024-12
Starpharma Holdings AUD 7.82M 3.39M 2024-12
Tectonic Therapeutic USD 22.33M 8.34M 2025-06
Telix Pharmaceuticals AUD 191.9M 130.08M 2024-12
Viatris USD 3.4B 2.88B 2025-06
Xeris Pharmaceuticals USD 67.06M 8.64M 2025-06


Neuren Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.